Endocare restates prior results after audit review
This article was originally published in Clinica
Executive Summary
Endocare, the Irvine, California-based ablation device firm, has restated its results for 2000 and 2001, and belatedly filed its 2002 results. It says it will shortly file its figures for the first two quarters of 2003, bringing it back into compliance with US Securities and Exchange Commission rules.